Concepedia
Statistics
Publications
23
Citations
1.2K
H-Index
18
Active since
1985
Affiliations
Eli Lilly (Spain)(Current)
Eli Lilly (United States)
Universidad de Extremadura
Universidad Autónoma de Madrid
Karolinska Institutet
Jesús Reviriego is an author at Eli Lilly (Spain) specializing in medicine, pharmacology, and diabetes.
Top concepts
MedicineDiabetesPharmacologyPhysiologyHealth EconomicsHealth PolicyPublic HealthHealthMetabolismGlobal Health
Publications per year
1985–2019
Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin
Leif Bertilsson, Ya‐Qing Lou, Yun-Long Du et al. · Clinical Pharmacology & Therapeutics · 1992 · 403 citations
Biology, Pronounced Differences, Chinese Subjects +15
Twice‐daily pre‐mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes
James Malone, Shuang Bai, Barbara N. Campaigne et al. · Diabetic Medicine · 2005 · 140 citations
A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus
Matthias Herz, Don Johns, Jesús Reviriego et al. · Clinical Therapeutics · 2003 · 132 citations
Diabetes Management, Cardiovascular Disease, Diabetes +6
Prevalence and clinical characteristics of metabolically healthy obese individuals and other obese/non-obese metabolic phenotypes in a working population: results from the Icaria study
Albert Goday, Eva Calvo, Luis Alberto Vázquez et al. · BMC Public Health · 2016 · 75 citations · Full text
Diazepam metabolism in native Chinese poor and extensive hydroxylators of S-mephenytoin: Interethnic differences in comparison with white subjects
Yuan Zhang, Jesús Reviriego, Ya‐Qing Lou et al. · Clinical Pharmacology & Therapeutics · 1990 · 57 citations
1–5 of 23